RK
Rajendra Kumar Chopra
About Rajendra Kumar Chopra
Data last updated:
Rajendra Kumar Chopra is a Company Secretary at Cipla Limited (since 2017), Director at Cipla Pharma And Life Sciences Limited (since 2019) and Director at Medispray Laboratories Private Limited (since 2025), and holds 6 more current directorships. The companies operate in Pharma, Healthcare and Entertainment. The 8 current companies with reported revenue have a combined latest revenue of ₹31,359 Cr; the largest is Cipla Limited at ₹29,045 Cr (FY 2026). Earlier, Rajendra Kumar Chopra was a Director at Bharti Insurance Holdings Private Limited (2015–2017) and Director at Cedent Private Limited (2015–2017) and 8 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cipla Limited L24239MH1935PLC002380 | Company Secretary | 09 Feb 2017 | 1935 | ₹29,045 Cr (FY 2026) | Active |
 Cipla Pharma And Life Sciences Limited U24239MH2008PLC381559 | Director | 02 Jan 2019 | 2008 | ₹1,598 Cr (FY 2025) | Active |
 Medispray Laboratories Private Limited U52311GA1992PTC002801 | Director | 29 Apr 2025 | 1992 | ₹444 Cr (FY 2025) | Active |
| Goldencross Pharma Limited U24239MH2000PLC123766 | Director | 03 Jan 2019 | 2000 | ₹188 Cr (FY 2025) | Active |
| Meditab Specialities Limited U23240MH1996PLC104442 | Director | 11 Nov 2024 | 1996 | ₹40.03 Cr (FY 2025) | Active |
 Inzpera Healthsciences Limited U74999MH2016PLC282701 | Director | 04 Dec 2025 | 2016 | ₹26.85 Cr (FY 2025) | Active |
| Cipla Digital Health Limited U72900MH2022PLC377512 | Director | 25 Feb 2022 | 2022 | ₹14.74 Cr (FY 2025) | Active |
| Cipla Pharmaceuticals Limited U24239MH2019PLC333266 | Director | 19 Nov 2019 | 2019 | ₹2.19 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bharti Insurance Holdings Private Limited U66010DL2010PTC211456 | Director | 16 Mar 2015 | 2010 | ₹206 Cr (FY 2016) | Amalgamated |
 Cedent Private Limited U74140DL2011FTC226246 | Director | 31 Mar 2015 | 2011 | ₹567 Cr (FY 2025) | Active |
 Carnegie Endowment For International Peace India U73200DL2013NPL260149 | Director | 06 Aug 2014 | 2013 | ₹14.65 Cr (FY 2025) | Active |
 Bharti Airtel Limited L74899HR1995PLC095967 | Company Secretary | 28 Apr 2015 | 1995 | ₹213,790 Cr (FY 2026) | Active |
| Augere Wireless Broadband India Private Limited U64200DL2010PTC207522 | Director | 18 Jan 2016 | 2010 | ₹2.94 Cr (FY 2016) | Amalgamated |
| Indo Teleports Limited U32204DL2008PLC183976 | Company Secretary | 16 Dec 2015 | 2008 | ₹16.57 Cr (FY 2025) | Active |
 Bharti Telecom Limited U32039HR1985PLC032091 | Company Secretary | 29 Apr 2005 | 1985 | ₹33,391 Cr (FY 2018) | Active |
 Future Retail Limited L51909MH2007PLC268269 | Director | 01 Dec 2014 | 2007 | ₹52.87 Cr (FY 2024) | Under Cirp |
| Mobinteco Limited U74140DL2011FLC226249 | Director | 31 Mar 2015 | 2011 | Amalgamated | |
 Bharti Infotel Private Limited U74899DL1983PTC015323 | Director | 23 Mar 2015 | 1983 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajendra Kumar Chopra
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajendra Kumar Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajendra Kumar Chopra
Rajendra Kumar Chopra currently holds 9 directorships: Cipla Limited (Company Secretary, since 09 Feb 2017, revenue ₹29,045 Cr (FY 2026)); Cipla Pharma And Life Sciences Limited (Director, since 02 Jan 2019, revenue ₹1,598 Cr (FY 2025)); Medispray Laboratories Private Limited (Director, since 29 Apr 2025, revenue ₹444 Cr (FY 2025)); Goldencross Pharma Limited (Director, since 03 Jan 2019, revenue ₹188 Cr (FY 2025)); Meditab Specialities Limited (Director, since 11 Nov 2024, revenue ₹40.03 Cr (FY 2025)); and 4 more.
Rajendra Kumar Chopra was first appointed on 29 Apr 2005 as Company Secretary at Bharti Tele Com Ltd. The most recent appointment on record is 04 Dec 2025 at Inzpera Healthsciences Limited.
The 8 current companies of Rajendra Kumar Chopra that report revenue have a combined latest revenue of ₹31,359 Cr: Cipla Limited ₹29,045 Cr (FY 2026); Cipla Pharma And Life Sciences Limited ₹1,598 Cr (FY 2025); Medispray Laboratories Private Limited ₹444 Cr (FY 2025); Goldencross Pharma Limited ₹188 Cr (FY 2025); Meditab Specialities Limited ₹40.03 Cr (FY 2025); and 3 more.
Rajendra Kumar Chopra held 10 earlier board appointments: Bharti Insurance Holdings Private Limited (Director, 16 Mar 2015 to 31 Jan 2017); Cedent Private Limited (Director, 31 Mar 2015 to 31 Mar 2017); Carnegie Endowment For International Peace India (Director, 06 Aug 2014 to 23 Mar 2016); Bharti Airtel Limited (Company Secretary, 28 Apr 2015 to 24 Jan 2017); Augere Wireless Broadband India Private Limited (Director, 18 Jan 2016 to 31 Jan 2017); and 5 more.
The current boards of Rajendra Kumar Chopra's companies include Abhijit Jagdish Joshi (Cipla Limited), Achin Gupta (Cipla Limited), Achin Gupta (Cipla Limited), Adil Zainulbhai (Cipla Limited), Balram Bhargava (Cipla Limited), Dinesh Ramniranjan Jain (Cipla Limited), among others.